circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury

Jiang Zhu1, Fukuan Zhong1, Futao Chen1

  • 1Department of Respiratory, The Second People's Hospital of Lianyungang, Lianyungang 222023, Jiangsu, China.

Insights

Circular RNA (circRNA) mmu-circ_0001679 promotes sepsis-induced acute lung injury (ALI). Knocking down this circRNA reduces inflammation and apoptosis, offering a potential therapeutic target for ALI treatment.

Area of Science:

  • Molecular Biology
  • Immunology
  • Respiratory Medicine

Background:

  • Acute lung injury (ALI) is a critical respiratory condition often caused by sepsis, leading to acute respiratory failure.
  • Circular RNA (circRNA) mmu-circ_0001679 has been observed to be overexpressed in sepsis-induced ALI models.
  • Understanding the specific role of circ_0001679 in ALI pathogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional role of circ_0001679 in the development of sepsis-induced ALI.
  • To elucidate the underlying molecular mechanism, including gene interactions and signaling pathways.
  • To evaluate the therapeutic potential of targeting circ_0001679 in ALI.

Main Methods:

  • Establishment of in vitro (MLE-12 cells) and in vivo (C57BL/6 mice) models of ALI induced by lipopolysaccharide (LPS).
  • Assessment of lung pathology, pulmonary permeability (W/D ratio, lung permeability index), inflammatory cytokine levels (TNF-α, IL-6, IL-1β) via ELISA, and apoptosis via flow cytometry.
  • Bioinformatics analysis and luciferase reporter assays to determine the interaction between circ_0001679, miR-338-3p, and DUSP16.

Main Results:

  • circ_0001679 was found to be significantly overexpressed in LPS-stimulated MLE-12 cells.
  • Knockdown of circ_0001679 effectively suppressed LPS-induced apoptosis and the production of pro-inflammatory cytokines.
  • circ_0001679 directly binds to mmu-miR-338-3p, which in turn targets DUSP16. DUSP16 overexpression reversed the protective effects of circ_0001679 knockdown.
  • In vivo, circ_0001679 knockdown attenuated lung injury, reduced pulmonary microvascular permeability, and suppressed inflammation in ALI mice.

Conclusions:

  • circ_0001679 plays a pro-inflammatory and pro-apoptotic role in sepsis-induced ALI.
  • The mechanism involves the circ_0001679/miR-338-3p/DUSP16 axis.
  • Targeting circ_0001679 represents a promising therapeutic strategy for inhibiting the progression of sepsis-induced ALI.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
370
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
411
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
224
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
383
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
378